NCT06596551 Aspirational Rehabilitation Coaching for Holistic Health (ARCH): A Pilot Pre-Post Experimental Study
| NCT ID | NCT06596551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanyang Technological University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-03-01 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ARCH programme is a novel, strength-based, dyadic, multicomponent psychosocial intervention that blends together psychoeducation, psychosocial support and self-compassion practices to aid first-time stroke survivors and their family caregivers with their psycho-socio-emotional and spiritual challenges following discharge from in-patient care. A pre-post experimental design with a feasibility and acceptability assessment is adopted to evaluate and refine the ARCH intervention in promoting wellbeing, self-compassion, independence, quality of life, hope, resilience, self-efficacy and dyadic mutuality.
Eligibility Criteria
Inclusion Criteria: * Aged 21 years and above * Recovering from their first stroke at mild to moderate degree of severity * Discharged from inpatient care at no later than 3 months, * Clinically assessed to have cognitive capacities to engage in and complete the research study, * Language capabilities in English or Mandarin, and * One identified primary family caregiver aged 21 years and above with similar language capabilities. Exclusion Criteria: * Families with survivors suffering from aphasia, * Being too ill to participate, * Experiencing moderate to severe cognitive impairment, and * With family caregivers who are not interested to participate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06596551 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06596551 currently recruiting?
Yes, NCT06596551 is actively recruiting participants. Contact the research team at andyhyho@ntu.edu.sg for enrollment information.
Where is the NCT06596551 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06596551 clinical trial?
NCT06596551 is sponsored by Nanyang Technological University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.